The verdict
Our read at a glance.
Whether urolithin A's modest effects in randomized trials on mitochondrial markers and muscle endurance support the broad anti-aging, energy, and performance claims made for it.
- The signal
- Randomized trials in older adults report that urolithin A can improve markers of mitochondrial health and modestly improve muscle endurance, with a good short-term safety record. The effects are real but small, and there is no evidence it extends lifespan or prevents disease.
- The unknown
- Whether its modest biomarker and endurance effects translate into meaningful long-term health or functional benefit, and how individual differences in gut bacteria affect natural urolithin production.
- Our read
- A supplement with real but modest human trial data, not a proven anti-aging therapy. Urolithin A genuinely affects mitochondrial markers and muscle endurance in trials, but the effects are small and the broad longevity and energy claims go well beyond the evidence.
The mechanism
How it works.
Urolithin A is a small molecule that gut bacteria produce when they break down ellagitannins from foods such as pomegranate and walnuts; most of it is sold as the synthesized supplement Mitopure because many people lack the bacteria to make much. The proposed mechanism is that it induces mitophagy, the process by which a cell tags and clears its damaged mitochondria so healthier ones can take over, which would improve the efficiency of muscle and other tissue. Randomized trials in older adults back a modest version of this, showing changes in mitochondrial markers and small endurance gains rather than dramatic effects.
Safety & regulatory boundary
The consequential part.
Urolithin A is sold as a supplement, not an approved drug, so it is not held to drug-level standards, and product content can vary. Its trials show modest, mostly biomarker and endurance effects, which do not establish anti-aging, disease-prevention, or major performance benefits. Supplement use is not the same as a tested medical treatment.
What's next
What we're watching.
Larger and longer trials with functional outcomes, and data on who benefits based on gut-bacteria differences.
Context
Why this is discussed.
Urolithin A is marketed as a mitochondrial and longevity supplement with actual human trials behind it, which sets it apart from many supplement claims and drives strong interest.
The evidence base
20 cited references.
Registered trials8
ClinicalTrials.gov · NA · RECRUITING · 2026-06-03
ClinicalTrials.gov · PHASE1 · COMPLETED · 2012-10-17
ClinicalTrials.gov · PHASE2 · RECRUITING · 2024-09-12
ClinicalTrials.gov · NA · COMPLETED · 2023-08-01
ClinicalTrials.gov · NA · COMPLETED · 2022-01-24
ClinicalTrials.gov · NA · NOT_YET_RECRUITING · 2026-05-01
ClinicalTrials.gov · NA · RECRUITING · 2025-12-10
ClinicalTrials.gov · NA · ACTIVE_NOT_RECRUITING · 2019-10-07
Indexed literature (PubMed)12
Singh A et al. · Cell Rep Med · 2022
D'Amico D et al. · Trends Mol Med · 2021
Kuerec AH et al. · Ageing Res Rev · 2024
Liu S et al. · JAMA Netw Open · 2022
Dao T et al. · Endocrinol Metab (Seoul) · 2020
García-Villalba R et al. · Mol Nutr Food Res · 2022
Zhang M et al. · Crit Rev Food Sci Nutr · 2023
Zelicha H et al. · BMC Med · 2022
Broome SC et al. · Sports Med · 2024
Denk D et al. · Nat Aging · 2025
Yaskolka Meir A et al. · BMC Med · 2023
Keep reading